* CABG patients - 57.3 percent
* No intervention patients - 66.3 percent
-- Aspirin therapy
* PCI patients - 99.4 percent
* CABG patients - 97.1 percent
* No intervention patients - 94.5 percent
-- Beta blockers
* PCI patients - 91 percent
* CABG patients - 90.8 percent
* No intervention patients - 88.2 percent
-- Smoking cessation counseling
* PCI patients - 84.8 percent
* CABG patients - 82.4 percent
* No intervention patients - 73.9 percent
-- Lipid drugs
* PCI patients - 89.2 percent
* CABG patients - 77.4 percent
* No intervention patients - 72.3 percent
Those patients who did receive all of the recommended performance measures were more often PCI patients -- 71.5 percent of those patients received all the measures, while 65.1 percent of all CABG patients received all of the measures and 62.1 percent of the no-intervention group of patients received all the measures.
"Even though these numbers are better than they have been, they are not as good as they could be in any of the groups -- in particular the group at highest risk, the surgical patients," said Hiratzka. "Though there were limitations to this study, it suggests that we need to improve our systems of care so that they are better geared to making sure that all heart disease patients are getting the information, guidance and treatment they need to prevent future cardiac events."
Co-authors are Kim A. Eagle, M.D.; Li Liang, Ph.D.; Gregg C. Fonarow, M.D.; Kenneth A. LaBresh, M.D. and Eric D. Peterson, M.D. for the GWTG Steering Committee.
Editor's Note: Get With The GuidelinesSM(GWTG) is the American Heart
Association and American Stroke Association's evidenced-based quality
improvement program that helps hospitals align their care for coronary
artery disease, stroke and heart failure patients with the latest
|SOURCE American Heart Association|
Copyright©2007 PR Newswire.
All rights reserved